Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @FaltasLab
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FaltasLab
-
Prikvačeni tweet
Very proud of the latest
@Faltaslab paper on the biology of upper tract urothelial carcinoma @NatureCommunications https://www.nature.com/articles/s41467-019-10873-y …@surrealistNYC@Panos_Vlach@ElementoLab@cornellGUcancer@nyphospital@WeillCornell Stay tuned for the Twitter explainer.pic.twitter.com/Llu8onKkvP
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
‘A Urine-Based Genomic Assay to Triage Patients with Hematuria for Cystoscopy’ in
@JUrology - https://www.ncbi.nlm.nih.gov/m/pubmed/31985322/ … cc@kim_vankessel@joostboormans@ESteyerberg@wvcrieki@ellen_zwarthoff@MDxHealth@Caba_L@bkcrotterdamHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
On
#WorldCancerDay
we asked #WCM experts: “What is the bravest thing we can do about cancer?” Dr. Melissa B. Davis (@MeliD32) of@EngIPM wants to find ways to make cancer treatment affordable.pic.twitter.com/HIeQXF5SuZHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
Improving the lives of all people with
#cancer relies on talent and insight from across the globe.#WorldCancerDay
pic.twitter.com/gCvn0SYgK2Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
Today, we join millions of people all over the world to observe
#WorldCancerDay
. Please help us help others by sharing this information about bladder cancer, the seventh-most frequently diagnosed cancer in the United States. https://bcan.org/learning-about-bladder-cancer/ …pic.twitter.com/EWB8x1v1CH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
Dr. R. R. Jeeta et al. investigate the frequency of 5 non-coding mutation hotspots in 302 urothelial bladder cancers (UBCs) and assess their potential for UBC detection and prognostication.
#DNAsequencing#NGS#genomics@BladderCaJrnl#openaccess https://content.iospress.com/articles/bladder-cancer/blc190251 …pic.twitter.com/U21eTEOqvI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
“Thank you for saving my life." Tomas Dahl (pictured left) was diagnosed with tonsil cancer and told there was no cure. But after trying the cancer therapy pioneered by the 2018 Medicine Laureates (centre and right), he emerged cancer-free.
#WorldCancerDay
pic.twitter.com/vidR7zGKUr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
Memorial Sloan Kettering is seeking a Chief of the Early Drug Development and Immunotherapy Service, whose mission is to lead the translation of novel cancer therapeutics from the lab to the clinic. Applicants should send a CV and brief statement to eddchiefsearch@mskcc.org.
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
NYC’s First Possible Coronavirus Patient Tested at Manhattan Hospitalhttps://www.nbcnewyork.com/news/local/nycs-first-possible-coronavirus-patient-tested-at-manhattan-hospital/2275229/?_osource=db_npd_nbc_wnbc_twt_shr …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
"One of the biggest takeaway messages [from the viral sequences] is that there was a single introduction into humans and then human-to-human spread"
@trvrb on the#Wuhan#coronavirus in@sciencemagazine@sciencecohen@nextstrainhttps://bit.ly/37NZ9tUHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
Physician interpretation of VUS. Over 75% make recommendations that are not warranted. Support
#HR3235@theACMG#GCchat#patientaccess https://www.ncbi.nlm.nih.gov/pubmed/29721668Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
I remember bookmarking all my favorite online C1V1=C2V2 and molarity calculators for creating stock solutions from powders
https://twitter.com/point_mutation/status/1223341696840171521 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
Clinical implications of the
#CARD trial cabazitaxel vs Abi or Enza in pts previously treated w/ docetaxel & had progression within 12 mths while receiving the alternative inhibitor.@cnsternberg@WeillCornell@CaPsurvivorship@NUFeinbergMed@PCFnews@NEJM http://bit.ly/2sjAYnq pic.twitter.com/MsMVTDT9HR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
Leading up to
#WorldCancerDay
on February 4, we are highlighting @DanaFarber and the Jimmy Fund’s global impact, so that one day, we can all live in a world without cancer. Meet Toni Choueiri, MD:pic.twitter.com/MmQjBvgfzE
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
PI broken record: you only know what experiments are left to do (and even how to prioritize them) once you start writing. Write now. BEFORE you think you’re done collecting data.
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The pleasure was mine to meet fantastic colleagues
@NicoleKuderer@gary_lymanhttps://twitter.com/NicoleKuderer/status/1222620255748608002 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2019 in Review: Advancements and Accomplishments https://weillcornellgucancer.org/2020/01/29/2019-in-review-advancements-and-accomplishments/ … via
@wordpressdotcomHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
Antibody-drug conjugates for metastatic urothelial carcinoma & 177Lu-PSMA-617 for progressive mCRPC.
@DrScottTagawa@WeillCornell and@CaPsurvivorship@NUFeinbergMed discuss advances in#BladderCancer &#ProstateCancer.#WatchNow on UroToday > http://bit.ly/2QSL88L@PCFnewspic.twitter.com/J2gZNiTqtm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
DrBishoyFaltas proslijedio/la je Tweet
So many of our BCAN community members have moving and inspiring stories about why they participate in their local Walk to End Bladder Cancer. We highlight those stories on "Why I Walk Wednesdays."
#WhyIWalk Register to participate in a walk near you: http://support.bcan.org/site/TR?fr_id=1692&pg=entry …pic.twitter.com/5lBdoYbp2i
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great overview of the evolving treatments of non-muscle invasive bladder cancer by
@garysteinbergmdhttps://twitter.com/EngIPM/status/1221879645819351043 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.